Tab 40 mg/Retard Cap
Edema ( cardiac, hepatic, renal;
edema due to burns), Hypertension.
Tab 500 mg/IV 250 mg
Acute renal failure. Chronic
renal failure in the predialytic stage. Terminal renal failure. Nephrotic
syndrome. Only indicated in greatly reduced glomerular filtration.
Edema ( cardiac, hepatic, renal,
cerebral; oedema due to burns). Acute heart failure (pulmonary oedema).
Hypertensive crisis. Poisoning (forced diuresis). Reduced urinary output in
gestosis. Prior to treatment, fluid volume must be restored to normal.
Tab 40 mg
20-80 mg daily. Children 2 mg/kg
body weight. Max: 40 mg/day.
30-60 mg daily. Children 2 mg/kg
body weight Max: 40 mg/day.
Tab 500 mg
Min: 250 mg. Max: 1.5 g/24 hour.
In exceptional cases, up to 2 g/24 hour.
Injection 20 mg
Min: 20 mg daily. Children 1
mg/kg body weight. Max: 20 mg/day.
Acute renal failure with anuria,
hepatic coma, hypokalemia, hyponatremia, hypovolemia with or without
hypotension. Impaired renal or hepatic function.
Pregnancy & lactation;
electrolyte & fluid imbalance; Impaired micturition. Diabetes, gout.
Minor gastrointestinal upset;
calsium, potassium & sodium depletion, nephrocalcinosis in premature
infants; aggravation of metabolic alkalosis; diabetes.
Anaphylactic shock, allergic
reactions, bone marrow depression; acute pancreatitis, auditory disorders.
Increased risk of ototoxicity
with aminoglycosides, cisplatin & nephrotoxicity with aminoglycosides,
cefaloridine. ACE inhibitors may cause marked fall in blood pressure.
Antagonism with indomethacin. Potentiation with salicylates, theophylline,
lithium & curare-type muscle relaxants. Hypokalemia may precipitate
Tab 40 mg x 250's. 500 mg x
SR cap 30 mg x 250's
Special ampoules 250 mg/25 mL x
Ampoules 20 mg/2 mL x 25's.